The Legal Challenges Facing Mifepristone

About this episode: In May, the Supreme Court issued an order preserving access to the abortion medication mifepristone by telemedicine—for now. In this episode: a breakdown of Louisiana v. FDA and other cases involving mifepristone as legal and political battles continue after the overturning of Roe v. Wade. Guest: Joanne Rosen, JD, MA, is an expert in public health law and a co-director of the Center for Law and the Public's Health at the Johns Hopkins Bloomberg School of Public Health. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. He served as the Baltimore City Commissioner of Health from 2005 to 2009. Show links and related content: Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court—KFF What Is Mifepristone, aka "The Abortion Pill"?—Johns Hopkins Bloomberg School of Public Health How the FDA Regulates Mifepristone, "the Abortion Pill"—Public Health On Call (February 2026) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.